INDV today
$36.28+$0.91 (+2.57%)close Nov 2, 2026Trend
DailyDowntrend (starting)
4 hourExpanding
1 hourStrong Bullish
15 minBearish
5 minAscending Triangle
Daily trend turns up above $42.81
Key levels
Resistance$38.56
Resistance$37.05
Support$35.36
Support$33.84
Latest news & SEC filings
NewsSupernus confirms special cash dividend for former Indivior stockholders
SEC FilingIndivior Pharmaceuticals, Inc. filed an insider trading report (Form 4)
All INDV news →About Indivior
Indivior is a pharmaceutical company focused on treatments for opioid use disorder and related conditions. Its main product is Sublocade, an injectable buprenorphine, along with other medicines such as Perseris and Subutex. The company sells primarily in the United States, with additional operations in Australia, Canada, France, and Germany, serving patients, healthcare providers, and payers.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Indivior Pharmaceuticals, Inc. (INDV)
What Is the Price Target for INDV?
SEPT Low Target
$36.55
SEPT Mid Target
$43.00
SEPT High Target
$49.45
Analyst Consensus
$43.00
Is INDV a Buy or Sell Right Now?
Thesis
- •Revenue growing 4.3% YoY with STABLE trend — consistent growth.
- •Smart money flows are positive — institutional and insider activity shows net buying.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INDV.
Start Free Trial →Is INDV Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG, Analyst Consensus
Fair Value
$59.36
57
Moat Score
NARROW
5/9
Piotroski Score
3.3
Altman Z-Score
What Is Smart Money Doing with INDV?
Insider Signal
BUYING
4 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Anderson Woodrow D | officer | Buy | 1,500 | $54K | Aug 27, 2026 |
| Heidbreder Christian | officer | Sale | 18,586 | $707K | Jun 11, 2026 |
| Preblick Ryan | officer | Sale | 36,000 | $1.4M | Jun 8, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →INDV Growth Story
Revenue YoY
4.3%
3yr Revenue CAGR
11.2%
EPS Growth YoY
3180%
FCF Growth YoY
-1428.6%
Revenue Trend
STABLE
Dark Pool Trades for INDV
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for INDV, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:52:11 | $36.28 | 1,218,300 | $$44.2M | SELL |
| 22:43:07 | $36.30 | 2,490 | $$90K | SELL |
| 21:20:00 | $36.28 | 4,705 | $$171K | BUY |
| 21:12:24 | $36.39 | 118,460 | $$4.3M | BUY |
| 21:05:33 | $36.28 | 155,000 | $$5.6M | BUY |
5 dark pool trades shown · $$54.4M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Indivior Pharmaceuticals, Inc. (INDV) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →INDV — frequently asked questions
What is INDV stock price today?
Indivior Pharmaceuticals, Inc. (INDV) is at $36.28, up 2.57% (+$0.91) at the Nov 2, 2026 close.
Why is INDV stock moving today?
Latest INDV news — Nov 6, 2026: Supernus confirms special cash dividend for former Indivior stockholders · Nov 4, 2026: Indivior Pharmaceuticals, Inc. filed an insider trading report (Form 4)
What is the INDV price target?
The average analyst price target for INDV is $43.00, ranging from $43 to $43, based on 1 analysts. Latest: Barclays maintains on Aug 5, 2026.
What do analysts rate INDV?
Analyst ratings for INDV: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did INDV beat earnings?
INDV last reported on Oct 29, 2026: EPS $1.32 vs $1.06 expected — a beat of 24.5%.
What is INDV's P/E ratio?
INDV trades at a P/E of 12.6 vs a Healthcare average of 18.4.
Does INDV pay a dividend?
INDV does not currently pay a dividend.
What are INDV support and resistance levels?
Support: $35.36, $33.84, $32.31. Resistance: $37.05, $38.56, $40.00.
What are insiders doing with INDV?
Insider activity: BUYING, 4 buys and 2 sells in the last 90 days.
What is the latest news on INDV?
Nov 6, 2026: Supernus confirms special cash dividend for former Indivior stockholders · Nov 4, 2026: Indivior Pharmaceuticals, Inc. filed an insider trading report (Form 4)